Takeda gets Japanese approval for US$62 billion Shire purchase


Takeda Pharmaceutical Co Ltd said on Thursday Japan's Fair Trade Commission had approved its US$62 billion acquisition of Shire Plc , bringing the Japanese firm closer to sealing a deal that will make it a global top 10 drugmaker. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo, Japan, July 2, 2018.



from Biotech News